UK Osteoarthritis Therapeutics Market Size & Outlook
UK osteoarthritis therapeutics market, 2018-2030 (US$M)
Related Markets
UK osteoarthritis therapeutics market highlights
- The UK osteoarthritis therapeutics market generated a revenue of USD 668.6 million in 2023 and is expected to reach USD 977.7 million by 2030.
- The UK market is expected to grow at a CAGR of 5.6% from 2024 to 2030.
- In terms of segment, viscosupplementation agents was the largest revenue generating drug type in 2023.
- Viscosupplementation Agents is the most lucrative drug type segment registering the fastest growth during the forecast period.
Osteoarthritis therapeutics market data book summary
| Market revenue in 2023 | USD 668.6 million |
| Market revenue in 2030 | USD 977.7 million |
| Growth rate | 5.6% (CAGR from 2023 to 2030) |
| Largest segment | Viscosupplementation agents |
| Fastest growing segment | Viscosupplementation Agents |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids, Others Drug Type |
| Key market players worldwide | GlaxoSmithKline Consumer Healthcare (GSK CH India), Sanofi SA, Pfizer Inc, Bayer AG, Zimmer Biomet Holdings Inc, Novartis AG ADR, Anika Therapeutics Inc, Assertio Holdings Inc, Bioventus Inc Class A |
Other key industry trends
- In terms of revenue, UK accounted for 7.8% of the global osteoarthritis therapeutics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany osteoarthritis therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- Denmark is the fastest growing regional market in Europe and is projected to reach USD 76.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Osteoarthritis Therapeutics Market Scope
Osteoarthritis Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK osteoarthritis therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to osteoarthritis therapeutics market will help companies and investors design strategic landscapes.
Viscosupplementation agents was the largest segment with a revenue share of 36.63% in 2023. Horizon Databook has segmented the UK osteoarthritis therapeutics market based on viscosupplementation agents, nonsteroidal anti-inflammatory drugs, analgesics, corticosteroids, others drug type covering the revenue growth of each sub-segment from 2018 to 2030.
- UK Osteoarthritis Therapeutics Drug Type Outlook (Revenue, USD Million, 2018-2030)
- Viscosupplementation Agents
- Nonsteroidal Anti-inflammatory Drugs
- Naproxen
- Aspirin
- Diclofenac
- Ibuprofen
- Celecoxib
- Meloxicam
- Piroxicam
- Ketoprofen
- Other NSAIDs
- Analgesics
- Duloxetine
- Acetaminophen
- Corticosteroids
- Others Drug Type
- UK Osteoarthritis Therapeutics Anatomy Outlook (Revenue, USD Million, 2018-2030)
- Knee Osteoarthritis
- Hip Osteoarthritis
- Hand Osteoarthritis
- Others Anatomy
- UK Osteoarthritis Therapeutics Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Parenteral Route
- Hyaluronic Acid Injections
- Corticosteroid Injections
- Platelet-rich Plasma (PRP) Injections
- Placental Tissue Matrix (PTM) Injections
- Acetylsalicylic Acid (ASA) Injections
- Other Parenteral Routes
- Topical Route
- Oral Route
- Parenteral Route
- UK Osteoarthritis Therapeutics Sales Channel Outlook (Revenue, USD Million, 2018-2030)
- Prescription Drugs
- Over-the-Counter Drugs
- UK Osteoarthritis Therapeutics End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacies
- Retail Pharmacies
- Other End-users
Reasons to subscribe to UK osteoarthritis therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK osteoarthritis therapeutics market databook
-
Our clientele includes a mix of osteoarthritis therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK osteoarthritis therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into UK osteoarthritis therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK osteoarthritis therapeutics market size, by drug type, 2018-2030 (US$M)
UK Osteoarthritis Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
